NASDAQ:IRTC iRhythm Technologies - IRTC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $100.10 +2.87 (+2.95%) (As of 01/27/2023 12:50 PM ET) Add Compare Share Share Today's Range$96.75▼$100.1750-Day Range$85.89▼$110.9052-Week Range$85.74▼$169.54Volume49,506 shsAverage Volume275,717 shsMarket Capitalization$3.01 billionP/E RatioN/ADividend YieldN/APrice Target$152.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media iRhythm Technologies MarketRank™ ForecastAnalyst RatingModerate Buy2.78 Rating ScoreUpside/Downside53.2% Upside$152.00 Price TargetShort InterestBearish5.51% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.14Based on 4 Articles This WeekInsider TradingSelling Shares$1.55 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($3.82) to ($2.67) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.37 out of 5 starsMedical Sector255th out of 1,055 stocksSurgical & Medical Instruments Industry27th out of 105 stocks 4.4 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $152.00, iRhythm Technologies has a forecasted upside of 53.2% from its current price of $99.21.Amount of Analyst CoverageiRhythm Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.51% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 6.41%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 3.4 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for iRhythm Technologies this week, compared to 2 articles on an average week.Search Interest2 people have searched for IRTC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,554,358.00 in company stock.Percentage Held by InsidersOnly 1.64% of the stock of iRhythm Technologies is held by insiders.Percentage Held by Institutions98.96% of the stock of iRhythm Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($3.82) to ($2.67) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -22.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -22.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 10.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About iRhythm Technologies (NASDAQ:IRTC) StockiRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Stock News HeadlinesJanuary 23, 2023 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Short Interest UpdateJanuary 23, 2023 | americanbankingnews.comAnalysts Set iRhythm Technologies, Inc. (NASDAQ:IRTC) Price Target at $157.22January 27, 2023 | Investing Trends (Ad)"TAKE THAT, CHINA!" USA Gains in EV Battery Arms RaceDid you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. January 17, 2023 | americanbankingnews.comContrasting Regenicin (OTCMKTS:RGIN) and iRhythm Technologies (NASDAQ:IRTC)January 9, 2023 | finance.yahoo.comiRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2023 | markets.businessinsider.com7 Analysts Have This to Say About iRhythm TechnologiesDecember 27, 2022 | finance.yahoo.comiRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 1, 2022 | finance.yahoo.comiRhythm Technologies' (NASDAQ:IRTC) growing losses don't faze investors as the stock advances 3.4% this past weekJanuary 27, 2023 | Investing Trends (Ad)"TAKE THAT, CHINA!" USA Gains in EV Battery Arms RaceDid you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. November 18, 2022 | seekingalpha.comiRhythm: Revenue Upside Less Visible After Q3 ChallengesNovember 14, 2022 | finance.yahoo.comShould You Consider iRhythm Technologies (IRTC) Shares for Investment?November 8, 2022 | finance.yahoo.comResults of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22November 4, 2022 | finance.yahoo.comCalculating The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)November 2, 2022 | finance.yahoo.comiRhythm Posts Smaller Than Expected Loss In Q3, But Shares Fall On Lowered Annual GuidanceNovember 2, 2022 | finance.yahoo.comiRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023November 2, 2022 | finance.yahoo.comiRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023November 1, 2022 | msn.comIRhythm Technologies (IRTC) Reports Q3 Loss, Misses Revenue EstimatesNovember 1, 2022 | finance.yahoo.comiRhythm Technologies Announces Third Quarter 2022 Financial ResultsOctober 20, 2022 | finance.yahoo.comiRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022October 11, 2022 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About iRhythm TechnologiesOctober 6, 2022 | nasdaq.comThe five-year returns have been strong for iRhythm Technologies (NASDAQ:IRTC) shareholders despite underlying losses increasingOctober 4, 2022 | nasdaq.comIRTC Makes Bullish Cross Above Critical Moving AverageSeptember 26, 2022 | 247wallst.comiRythm’s Stock Slides -21% as Investor Day and Future Targets DisappointSeptember 24, 2022 | seekingalpha.comIRTC iRhythm Technologies, Inc.September 21, 2022 | marketwatch.comiRhythm Technologies Shares Tumble 11% Following Investor Day OutlookSeptember 4, 2022 | finance.yahoo.comiRhythm Technologies, Inc. (IRTC)September 2, 2022 | markets.businessinsider.com6 Analysts Have This to Say About iRhythm TechnologiesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Company Calendar Last Earnings11/01/2022Today1/27/2023Next Earnings (Confirmed)2/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees1,700Year FoundedN/APrice Target and Rating Average Stock Price Forecast$152.00 High Stock Price Forecast$198.00 Low Stock Price Forecast$105.00 Forecasted Upside/Downside+51.8%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($4.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-101,360,000.00 Net Margins-33.79% Pretax Margin-33.72% Return on Equity-39.31% Return on Assets-22.42% Debt Debt-to-Equity Ratio0.15 Current Ratio3.42 Quick Ratio3.25 Sales & Book Value Annual Sales$322.83 million Price / Sales9.34 Cash FlowN/A Price / Cash FlowN/A Book Value$9.50 per share Price / Book10.54Miscellaneous Outstanding Shares30,111,000Free Float29,617,000Market Cap$3.01 billion OptionableOptionable Beta1.44 Key ExecutivesMr. Quentin S. Blackford (Age 44)Pres, CEO & Director Comp: $671.81kMr. Douglas J. Devine (Age 53)COO & Sec. Comp: $1.14MMr. Mark J. Day Ph.D. (Age 52)Chief Technology Officer Comp: $718.76kMr. David A. Vort (Age 57)Strategic Advisor Comp: $896.16kMr. Daniel G. Wilson (Age 41)Exec. VP of Corp. Strategy Comp: $670.09kMr. Brice Bobzien CPAChief Financial OfficerDr. Mintu P. Turakhia M.D.M.S., Chief Medical Officer & Chief Scientific OfficerMr. Patrick Michael Murphy J.D. (Age 44)Chief Legal Officer Ms. Reyna M. Fernandez (Age 56)Exec. VP & Chief HR Officer Mr. Mazi KianiSr. VP of Quality & RegulatoryMore ExecutivesKey CompetitorsAxonicsNASDAQ:AXNXTandem Diabetes CareNASDAQ:TNDMInari MedicalNASDAQ:NARINuVasiveNASDAQ:NUVAGlaukosNYSE:GKOSView All CompetitorsInsiders & InstitutionsStephens Investment Management Group LLCBought 1,444 shares on 1/26/2023Ownership: 0.958%Strs OhioSold 4,100 shares on 1/26/2023Ownership: 0.021%Allspring Global Investments Holdings LLCSold 87,318 shares on 1/23/2023Ownership: 1.867%WoodTrust Financial CorpBought 500 shares on 1/23/2023Ownership: 0.034%Exchange Traded Concepts LLCBought 167,255 shares on 1/18/2023Ownership: 0.590%View All Insider TransactionsView All Institutional Transactions IRTC Stock - Frequently Asked Questions Should I buy or sell iRhythm Technologies stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks. What is iRhythm Technologies' stock price forecast for 2023? 9 analysts have issued twelve-month target prices for iRhythm Technologies' shares. Their IRTC share price forecasts range from $105.00 to $198.00. On average, they anticipate the company's stock price to reach $152.00 in the next year. This suggests a possible upside of 54.7% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts. How have IRTC shares performed in 2023? iRhythm Technologies' stock was trading at $93.67 at the start of the year. Since then, IRTC shares have increased by 4.9% and is now trading at $98.24. View the best growth stocks for 2023 here. When is iRhythm Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023. View our IRTC earnings forecast. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) released its quarterly earnings data on Tuesday, November, 1st. The company reported ($0.63) earnings per share for the quarter, topping analysts' consensus estimates of ($0.82) by $0.19. The business had revenue of $103.88 million for the quarter, compared to analyst estimates of $106.43 million. iRhythm Technologies had a negative net margin of 33.79% and a negative trailing twelve-month return on equity of 39.31%. What guidance has iRhythm Technologies issued on next quarter's earnings? iRhythm Technologies updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $407.00 million-$411.00 million, compared to the consensus revenue estimate of $418.72 million. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA). When did iRhythm Technologies IPO? (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is iRhythm Technologies' stock symbol? iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC." Who are iRhythm Technologies' major shareholders? iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.87%), Stephens Investment Management Group LLC (0.96%), Exchange Traded Concepts LLC (0.59%), Peregrine Capital Management LLC (0.29%), WoodTrust Financial Corp (0.03%) and Strs Ohio (0.02%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Quentin S Blackford, Ralph Snyderman and Raymond W Scott. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iRhythm Technologies' stock price today? One share of IRTC stock can currently be purchased for approximately $98.24. How much money does iRhythm Technologies make? iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $2.96 billion and generates $322.83 million in revenue each year. The company earns $-101,360,000.00 in net income (profit) each year or ($4.32) on an earnings per share basis. How many employees does iRhythm Technologies have? The company employs 1,700 workers across the globe. How can I contact iRhythm Technologies? iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com. This page (NASDAQ:IRTC) was last updated on 1/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.